Literature DB >> 22595727

Gastric cancer carcinogenesis and tumor progression.

Giovanni Corso1, Raquel Seruca, Franco Roviello.   

Abstract

BACKGROUND: Gastric cancer (GC) remains one of the leading causes of cancer-related deaths worldwide, even though a decline has been observed in its incidence and the mortality rate in recent decades. Gastric carcinogenesis is a complex phenomena involving multiple epigenetic and genetic factors; several genetic, environmental and infectious agents interact causing a cumulative effect in the early steps of gastric carcinogenesis.
MATERIALS AND METHODS: The most commonly used classifications of GC are the World Health Organization (WHO) and the Laurén classifications which describes two main histological types, diffuse and intestinal, which have different clinicopathological characteristics. Diffuse cancer occurs more commonly in young patients, can be multifocal, is not often accompanied by intestinal metaplasia and can be hereditary, in which E-cadherin alteration plays a pivotal role. Intestinal type is more frequently observed in older patients and follows multifocal atrophic gastritis. This is usually accompanied by intestinal metaplasia and leads to cancer via dysplasia, and thus intestinal metaplasia is considered a dependable morphological marker for GC risk. Intestinal adenocarcinoma predominates in the high-risk areas whereas the diffuse adenocarcinoma is more common in low-risk areas. DISCUSSION: Classically, genetic instability and Helicobater pylori (H. Pylori) infection are often identified in intestinal GC. The great majority of GCs are sporadic and result from the cumulative effects of different environmental risk factors; smoking, alcohol consumption and dietary habits have been addressed as significant. H. Pylori infection and proinflammatory cytokine gene polymorphisms represent other features of this compound process that leads to the development of GC. Other molecular pathway well described in GC is microsatellite instability (MSI) that related with specific clinic-pathological features.
CONCLUSION: In this review we focused on the role of H. Pylori infection, MSI and alterations of CDH1 (E-Cadherin) gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595727

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  12 in total

1.  Histamine and histamine receptor regulation of gastrointestinal cancers.

Authors:  Lindsey Kennedy; Kyle Hodges; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-10

2.  Sarcomatoid carcinoma of the stomach: A case report and literature review.

Authors:  Chun-Chao Zhu; Mao-Ran Li; Tian-Long Lin; Gang Zhao
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

Review 3.  Microarray analysis in gastric cancer: a review.

Authors:  Giovanna D'Angelo; Teresa Di Rienzo; Veronica Ojetti
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer.

Authors:  Tae Hoon Ha; Byeong Gwan Kim; Donghyong Jeong; Sohee Oh; Won Kim; Yong Jin Jung; Dong Won Ahn; Ji Bong Jeong; Ji Won Kim; Kook Lae Lee; Seong-Joon Koh
Journal:  Dig Dis Sci       Date:  2016-10-26       Impact factor: 3.199

Review 5.  Pathogenetic mechanisms in gastric cancer.

Authors:  Jing Shi; Yi-Ping Qu; Peng Hou
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Sarcomatoid carcinoma of the stomach: A very rare and extremely aggressive tumor; a case report.

Authors:  Mohamed Amine Elghali; Mehdi Ben Abdelkrim; Soumaya Mrabet; Emna Aloui; Amal Letaief; Marwa Krifa; Mohamed Hedi Mraidha; Imtinene Belaid
Journal:  Ann Med Surg (Lond)       Date:  2022-06-17

7.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

8.  Biological and clinical implications of endocan in gastric cancer.

Authors:  Wenyan Zhao; Ming Sun; Shuqiang Li; Yong Wang; Jingang Liu
Journal:  Tumour Biol       Date:  2014-07-11

9.  Association between Genetic Polymorphisms in Superoxide Dismutase Gene Family and Risk of Gastric Cancer.

Authors:  Alireza Eftekhari; Zahra Peivand; Iraj Saadat; Mostafa Saadat
Journal:  Pathol Oncol Res       Date:  2018-09-21       Impact factor: 3.201

10.  Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.

Authors:  Tamotsu Sugai; Makoto Eizuka; Noriyuki Arakawa; Mitsumasa Osakabe; Wataru Habano; Yasuko Fujita; Eiichiro Yamamoto; Hiroo Yamano; Masaki Endoh; Takayuki Matsumoto; Hiromu Suzuki
Journal:  Gastric Cancer       Date:  2018-02-21       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.